Diagnostic accuracy of FluoroType MTB stratified by light-emitting diode fluorescence smear microscopy positivity, HIV status and Xpert MTB/RIF result
| Culture positive (n=70) | Culture negative (n=226) | All | Sensitivity | Specificity | |||
| FluoroType MTB positive | FluoroType MTB negative | FluoroType MTB positive | FluoroType MTB negative | ||||
| Overall | 62 | 8 | 91 | 135 | 296 | 88.6% (78.7–94.9%) | 59.7% (53–66.2%) |
| Smear positive | 50 | 0 | 11 | 6 | 67 | 100% (92.9–100%) | 35.3% (14.2–61.7%) |
| Smear negative | 12 | 8 | 80 | 129 | 229 | 60.0% (36.1–80.9%) | 61.7% (54.8–68.3%) |
| HIV positive | 21 | 4 | 44 | 50 | 119 | 84.0% (63.9–95.5%) | 53.2% (42.6–63.6%) |
| HIV negative | 33 | 0 | 27 | 46 | 106 | 100% (89.4–100%) | 63.0% (50.9–74.0%) |
| HIV unknown | 8 | 4 | 20 | 39 | 71 | 66.7% (34.9–90.1%) | 66.1% (52.6–77.9%) |
| Xpert MTB/RIF positive | 53 | 2 | 13 | 1 | 69 | 96.4% (87.5–99.6%) | 7.1% (0.2–33.9%) |
| Xpert MTB/RIF negative | 9 | 6 | 78 | 134 | 227 | 60.0% (32.3–83.7%) | 63.2% (56.3–69.7%) |
Data in parentheses are 95% confidence intervals.